logo-loader
viewBioTelemetry Inc

BioTelemetry tops 3Q estimates as patient volume growth climbs higher, raises outlook

The medical technology company raised its full-year revenue outlook

Glucose monitor on a table
BioTelemetry provides cardiac and mobile blood glucose monitoring and other services to the healthcare industry

BioTelemetry Inc (NASDAQ:BEAT) announced better-than-expected third quarter earnings, swinging to a profit compared with the previous quarter as patient volume growth climbs.

The medical technology company reported earnings of $0.45 per share on revenue of $100 million compared with a net loss of $0.07 per share on revenue of $81 million in the previous year’s third quarter.

READ: Cardiovascular Systems tops revenue estimates in its first quarter

The Pennsylvania-based company beat Wall Street estimates of US$0.32 EPS on revenue of $97.92 million.

Shares of the company surged 8% to $55.05 in Tuesday after-hours trading.

“In addition to the continued volume strength, a favorable payor and product mix also had a positive impact on our revenue in the quarter,” said CEO Joseph H. Capper in the company’s press release.

BioTelemetry provides cardiac and mobile blood glucose monitoring, centralized medical imaging, and original equipment manufacturing services for the healthcare and clinical research industries.

For the year ahead, the company raised its revenue outlook to $397 million to $400 million with an adjusted EBITDA margin of about 28% compared with its previous guidance of revenue between $392 million to $395 million with an adjusted EBITDA margin of about 26%.

 

Contact Lenore Fedow at [email protected]

Follow her on Twitter@LenoreMariee

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Thunderbird releases financial numbers as company continues...

Thunderbird Entertainment (CVE: TBRD) Chairman Brian Paes-Braga sat down with Steve Darling from Proactive Investors Vancouver to discuss the company releasing their financial numbers for Fiscal 2019. Paes-Braga addressing the numbers and the one-time non-cash go public charge. Paes-Braga...

3 hours, 53 minutes ago

2 min read